Projects funded by the NCN
Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the colorectal cancer treatment
2016/23/B/NZ5/02630
Keywords:
PERK inhibitors colorectal cancer
Descriptors:
- NZ5_3: Pathogenesis of human diseases
- NZ5_7: Human disease treatment
- NZ2_1: Molecular genetics
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Medyczny w Łodzi, Wydział Lekarski
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 12 - announced on 2016-09-15
Amount awarded: 1 370 050 PLN
Project start date (Y-m-d): 2017-08-04
Project end date (Y-m-d): 2023-06-03
Project duration:: 70 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.